| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Receptor, Nerve Growth Factor | 11 | 2002 | 3 |
Why?
|
Neuroblastoma | 20 | 1987 | 36 |
Why?
|
Zinostatin | 21 | 1989 | 1 |
Why?
|
Apoptosis | 31 | 1993 | 265 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 16 | 1996 | 71 |
Why?
|
Oxidative Stress | 9 | 1997 | 119 |
Why?
|
Receptor, trkA | 9 | 1996 | 6 |
Why?
|
PC12 Cells | 21 | 1997 | 27 |
Why?
|
Neurology | 5 | 2003 | 28 |
Why?
|
Receptors, Nerve Growth Factor | 6 | 1996 | 11 |
Why?
|
Neurons | 11 | 1989 | 195 |
Why?
|
Brain | 10 | 1988 | 305 |
Why?
|
Antibiotics, Antineoplastic | 8 | 1989 | 35 |
Why?
|
Poetry as Topic | 3 | 2006 | 1 |
Why?
|
Oxidopamine | 11 | 1987 | 21 |
Why?
|
Antineoplastic Agents | 11 | 1992 | 190 |
Why?
|
Education, Medical | 4 | 2003 | 79 |
Why?
|
Animals | 63 | 1980 | 1031 |
Why?
|
Transfection | 14 | 1996 | 237 |
Why?
|
Brain Neoplasms | 5 | 1995 | 116 |
Why?
|
Rats | 26 | 1983 | 530 |
Why?
|
Cyclic N-Oxides | 3 | 1996 | 9 |
Why?
|
Spinal Cord Neoplasms | 2 | 2008 | 17 |
Why?
|
Program Development | 2 | 2005 | 61 |
Why?
|
Nerve Tissue Proteins | 3 | 2005 | 128 |
Why?
|
Mentors | 4 | 2003 | 22 |
Why?
|
Alzheimer Disease | 5 | 2003 | 71 |
Why?
|
Mice | 33 | 1980 | 623 |
Why?
|
Reactive Oxygen Species | 5 | 1996 | 112 |
Why?
|
Nuclear Proteins | 2 | 2009 | 139 |
Why?
|
Caspases | 5 | 2001 | 58 |
Why?
|
Glutathione | 9 | 1987 | 65 |
Why?
|
Humans | 58 | 1980 | 1856 |
Why?
|
Cholesterol | 2 | 2005 | 86 |
Why?
|
Nerve Growth Factors | 4 | 1993 | 43 |
Why?
|
Neural Crest | 4 | 1991 | 10 |
Why?
|
Signal Transduction | 11 | 2000 | 313 |
Why?
|
Education, Medical, Undergraduate | 3 | 1995 | 61 |
Why?
|
Faculty, Medical | 3 | 1998 | 45 |
Why?
|
Glioma | 4 | 1995 | 51 |
Why?
|
Tumor Cells, Cultured | 15 | 1989 | 233 |
Why?
|
Nervous System Neoplasms | 3 | 1991 | 8 |
Why?
|
Membrane Proteins | 4 | 2003 | 233 |
Why?
|
Problem-Based Learning | 3 | 1995 | 36 |
Why?
|
Cell Line, Tumor | 8 | 2003 | 208 |
Why?
|
Antioxidants | 6 | 1995 | 84 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2004 | 32 |
Why?
|
Aging | 2 | 2006 | 275 |
Why?
|
Cell Survival | 9 | 1993 | 229 |
Why?
|
Nervous System Diseases | 3 | 1992 | 78 |
Why?
|
Amifostine | 7 | 1980 | 15 |
Why?
|
Brain Diseases | 2 | 1998 | 75 |
Why?
|
Leadership | 1 | 2011 | 24 |
Why?
|
Neuroprotective Agents | 3 | 1996 | 60 |
Why?
|
Early Termination of Clinical Trials | 1 | 2011 | 3 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2011 | 11 |
Why?
|
Azepines | 1 | 2011 | 10 |
Why?
|
Guidelines as Topic | 1 | 2011 | 77 |
Why?
|
Alanine | 1 | 2011 | 32 |
Why?
|
Caspase 3 | 6 | 2001 | 56 |
Why?
|
Drug Delivery Systems | 1 | 2011 | 55 |
Why?
|
Gene Expression Regulation | 7 | 1999 | 277 |
Why?
|
Drug Resistance | 2 | 2005 | 83 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2006 | 32 |
Why?
|
Dopamine | 4 | 1991 | 62 |
Why?
|
Neurodegenerative Diseases | 1 | 2010 | 30 |
Why?
|
Neoplasms, Experimental | 2 | 2006 | 72 |
Why?
|
Dementia | 1 | 2010 | 56 |
Why?
|
Lipid Peroxidation | 5 | 1997 | 23 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2009 | 54 |
Why?
|
Molecular Biology | 1 | 2008 | 38 |
Why?
|
Tyrosine | 1 | 2009 | 71 |
Why?
|
Cyclins | 2 | 2001 | 28 |
Why?
|
Child | 14 | 1980 | 749 |
Why?
|
Workload | 1 | 2008 | 37 |
Why?
|
Down-Regulation | 2 | 2006 | 150 |
Why?
|
Biomedical Research | 2 | 2005 | 87 |
Why?
|
Nitrogen Oxides | 2 | 2003 | 11 |
Why?
|
Gene Expression | 3 | 1995 | 291 |
Why?
|
Cell Differentiation | 7 | 1993 | 262 |
Why?
|
Catecholamines | 2 | 2004 | 40 |
Why?
|
RNA, Small Interfering | 4 | 2006 | 116 |
Why?
|
Academic Medical Centers | 1 | 2008 | 65 |
Why?
|
Gene Transfer Techniques | 1 | 2008 | 59 |
Why?
|
Computer-Assisted Instruction | 2 | 1995 | 16 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2003 | 135 |
Why?
|
Lymphoma | 1 | 2008 | 96 |
Why?
|
Phosphorylation | 5 | 2002 | 224 |
Why?
|
Organothiophosphorus Compounds | 5 | 1980 | 3 |
Why?
|
Glutamate-Ammonia Ligase | 3 | 1988 | 3 |
Why?
|
Education, Medical, Graduate | 1 | 2008 | 70 |
Why?
|
Cell Death | 4 | 1995 | 94 |
Why?
|
Phosphatidylserines | 4 | 1999 | 13 |
Why?
|
Stillbirth | 1 | 2006 | 4 |
Why?
|
Medicine in Literature | 1 | 2006 | 4 |
Why?
|
Proteins | 1 | 2010 | 192 |
Why?
|
Status Epilepticus | 1 | 2005 | 7 |
Why?
|
Glutamate-Cysteine Ligase | 3 | 1988 | 17 |
Why?
|
Antigens, CD56 | 1 | 2005 | 16 |
Why?
|
Competency-Based Education | 1 | 2005 | 18 |
Why?
|
bcl-2-Associated X Protein | 4 | 2001 | 40 |
Why?
|
Parkinsonian Disorders | 1 | 2005 | 19 |
Why?
|
Breast Neoplasms | 3 | 1999 | 185 |
Why?
|
Propofol | 1 | 2005 | 27 |
Why?
|
Encephalomyelitis, Acute Disseminated | 1 | 2004 | 3 |
Why?
|
Dose-Response Relationship, Drug | 7 | 1994 | 431 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 104 |
Why?
|
Internship and Residency | 1 | 2008 | 175 |
Why?
|
Anticonvulsants | 1 | 2005 | 61 |
Why?
|
Serum Albumin | 1 | 2004 | 55 |
Why?
|
Adrenergic Agents | 2 | 1996 | 5 |
Why?
|
Albumins | 1 | 2004 | 33 |
Why?
|
Physician-Patient Relations | 1 | 2008 | 111 |
Why?
|
Infant, Premature | 1 | 2006 | 70 |
Why?
|
Migraine Disorders | 1 | 2003 | 11 |
Why?
|
Infant, Newborn | 4 | 1981 | 389 |
Why?
|
Proto-Oncogene Proteins | 4 | 1996 | 113 |
Why?
|
Embryonic Induction | 1 | 2003 | 8 |
Why?
|
Glomerular Mesangium | 1 | 2003 | 5 |
Why?
|
Genes, bcl-2 | 3 | 1997 | 19 |
Why?
|
Hydroxydopamines | 4 | 1987 | 13 |
Why?
|
Brain Chemistry | 1 | 2003 | 60 |
Why?
|
Gentamicins | 1 | 2003 | 32 |
Why?
|
Blotting, Western | 6 | 1995 | 275 |
Why?
|
Neurites | 2 | 1995 | 15 |
Why?
|
Child Welfare | 1 | 2003 | 41 |
Why?
|
Referral and Consultation | 1 | 2003 | 134 |
Why?
|
Iron | 2 | 1996 | 75 |
Why?
|
Mice, Inbred C57BL | 6 | 1987 | 318 |
Why?
|
Disulfides | 2 | 1990 | 18 |
Why?
|
Protein Structure, Tertiary | 4 | 2005 | 163 |
Why?
|
Practice Guidelines as Topic | 1 | 2003 | 174 |
Why?
|
Polymyositis | 1 | 2000 | 8 |
Why?
|
Behcet Syndrome | 1 | 2000 | 8 |
Why?
|
Sulfhydryl Compounds | 7 | 1980 | 42 |
Why?
|
Gene Expression Profiling | 4 | 2005 | 138 |
Why?
|
Prodrugs | 2 | 1996 | 16 |
Why?
|
Transferrin | 1 | 2000 | 22 |
Why?
|
Oxidation-Reduction | 7 | 1995 | 124 |
Why?
|
Peptide Synthases | 2 | 1988 | 4 |
Why?
|
Nerve Growth Factor | 3 | 2002 | 20 |
Why?
|
Arthritis, Rheumatoid | 1 | 2000 | 53 |
Why?
|
Cells, Cultured | 6 | 1995 | 447 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2000 | 52 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 1996 | 27 |
Why?
|
Free Radicals | 4 | 1987 | 25 |
Why?
|
Spin Labels | 3 | 1996 | 6 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 2 | 2008 | 5 |
Why?
|
Hydroxyl Radical | 3 | 2000 | 15 |
Why?
|
Anti-Bacterial Agents | 1 | 2003 | 195 |
Why?
|
Estradiol | 1 | 1999 | 78 |
Why?
|
Presenilin-1 | 4 | 2003 | 6 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1998 | 33 |
Why?
|
DNA Damage | 2 | 1995 | 66 |
Why?
|
Enzyme Inhibitors | 3 | 2002 | 216 |
Why?
|
Oxygen | 3 | 1988 | 179 |
Why?
|
Diagnostic Tests, Routine | 1 | 1998 | 34 |
Why?
|
Survival Rate | 2 | 2009 | 250 |
Why?
|
NF-kappa B | 3 | 2002 | 114 |
Why?
|
Mitosis | 1 | 1998 | 68 |
Why?
|
Drug Interactions | 4 | 1993 | 111 |
Why?
|
Pheochromocytoma | 2 | 1996 | 21 |
Why?
|
Adrenal Gland Neoplasms | 2 | 1996 | 25 |
Why?
|
Pennsylvania | 3 | 2003 | 16 |
Why?
|
Free Radical Scavengers | 2 | 1995 | 26 |
Why?
|
Nerve Degeneration | 1 | 1997 | 43 |
Why?
|
Neoplasm Proteins | 3 | 1989 | 110 |
Why?
|
Schools, Medical | 3 | 2003 | 46 |
Why?
|
Neoplasms | 1 | 2004 | 239 |
Why?
|
Time Factors | 6 | 1988 | 896 |
Why?
|
Educational Measurement | 1 | 1997 | 60 |
Why?
|
Information Science | 1 | 1995 | 1 |
Why?
|
Child, Preschool | 6 | 1981 | 554 |
Why?
|
Neoplasm Transplantation | 3 | 1994 | 67 |
Why?
|
Male | 13 | 1980 | 1553 |
Why?
|
Phospholipids | 4 | 1997 | 52 |
Why?
|
Adolescent | 6 | 1980 | 891 |
Why?
|
Mice, Inbred A | 4 | 1988 | 15 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 2 | 2005 | 13 |
Why?
|
Blotting, Northern | 2 | 2005 | 151 |
Why?
|
Decision Support Techniques | 1 | 1995 | 43 |
Why?
|
Antibodies, Monoclonal | 3 | 2002 | 241 |
Why?
|
Retrospective Studies | 3 | 2003 | 653 |
Why?
|
Nitrites | 2 | 2003 | 19 |
Why?
|
Enzyme Activation | 2 | 2005 | 177 |
Why?
|
GTP-Binding Proteins | 1 | 1995 | 47 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 1993 | 9 |
Why?
|
Anoxia | 2 | 1991 | 85 |
Why?
|
Drug Synergism | 5 | 1987 | 104 |
Why?
|
Transcription Factor CHOP | 2 | 2008 | 7 |
Why?
|
Electron Spin Resonance Spectroscopy | 4 | 1996 | 17 |
Why?
|
Mutagenesis, Site-Directed | 2 | 1996 | 126 |
Why?
|
Kinetics | 6 | 1988 | 349 |
Why?
|
Flow Cytometry | 2 | 2005 | 216 |
Why?
|
Female | 10 | 1981 | 1643 |
Why?
|
Paraneoplastic Syndromes | 1 | 1992 | 9 |
Why?
|
Cell Membrane | 4 | 1993 | 170 |
Why?
|
Endoplasmic Reticulum | 2 | 2008 | 59 |
Why?
|
Cisplatin | 3 | 1996 | 43 |
Why?
|
Nervous System | 1 | 1992 | 52 |
Why?
|
Risk | 2 | 1981 | 203 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2001 | 19 |
Why?
|
Transcription, Genetic | 3 | 2003 | 253 |
Why?
|
Cell Count | 2 | 1998 | 163 |
Why?
|
Mice, Transgenic | 4 | 2005 | 209 |
Why?
|
Cystic Fibrosis | 4 | 1980 | 31 |
Why?
|
Prader-Willi Syndrome | 1 | 2011 | 6 |
Why?
|
Cerebellum | 1 | 1991 | 59 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 26 |
Why?
|
Binding Sites | 2 | 2002 | 213 |
Why?
|
DNA | 1 | 1996 | 262 |
Why?
|
Pyridines | 1 | 1991 | 61 |
Why?
|
Models, Biological | 2 | 2001 | 410 |
Why?
|
Amyloid beta-Peptides | 1 | 2011 | 24 |
Why?
|
Cysteamine | 1 | 1990 | 3 |
Why?
|
Brain Ischemia | 1 | 1991 | 45 |
Why?
|
Religion | 1 | 2010 | 14 |
Why?
|
Radiation-Protective Agents | 1 | 1990 | 28 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 50 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2009 | 12 |
Why?
|
Disease Models, Animal | 3 | 1983 | 349 |
Why?
|
Students, Medical | 2 | 1998 | 66 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2009 | 12 |
Why?
|
Oncogene Protein v-akt | 1 | 2009 | 4 |
Why?
|
Combined Modality Therapy | 1 | 2011 | 219 |
Why?
|
Cerebral Cortex | 2 | 2008 | 108 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 51 |
Why?
|
Hybridomas | 1 | 2009 | 31 |
Why?
|
Mice, Nude | 3 | 2002 | 72 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2009 | 18 |
Why?
|
Liver | 3 | 1987 | 248 |
Why?
|
Polylysine | 1 | 2008 | 11 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2009 | 37 |
Why?
|
Protein Kinase Inhibitors | 1 | 2009 | 59 |
Why?
|
Drug Resistance, Multiple | 1 | 2008 | 19 |
Why?
|
Neurogenesis | 1 | 2008 | 18 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2009 | 36 |
Why?
|
Adult | 6 | 1980 | 1317 |
Why?
|
Frontal Lobe | 2 | 2005 | 33 |
Why?
|
Sleep Deprivation | 1 | 2008 | 6 |
Why?
|
Oxidants | 3 | 2000 | 47 |
Why?
|
Pituitary Neoplasms | 1 | 2008 | 25 |
Why?
|
Medical Staff, Hospital | 1 | 2008 | 31 |
Why?
|
Education | 1 | 2008 | 28 |
Why?
|
Quality Control | 1 | 2008 | 54 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2008 | 19 |
Why?
|
Burnout, Professional | 1 | 2008 | 13 |
Why?
|
Medulloblastoma | 1 | 2008 | 13 |
Why?
|
Immunotherapy | 1 | 2008 | 48 |
Why?
|
Glioblastoma | 1 | 2008 | 44 |
Why?
|
Hypoxia, Brain | 1 | 2008 | 15 |
Why?
|
Animals, Newborn | 2 | 1991 | 175 |
Why?
|
Cell Culture Techniques | 1 | 2008 | 74 |
Why?
|
Safety | 1 | 2008 | 80 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2009 | 67 |
Why?
|
Lipids | 1 | 2008 | 97 |
Why?
|
Genes, Reporter | 1 | 2008 | 111 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 1996 | 82 |
Why?
|
Structure-Activity Relationship | 3 | 1990 | 124 |
Why?
|
Analysis of Variance | 2 | 1991 | 339 |
Why?
|
Green Fluorescent Proteins | 1 | 2008 | 105 |
Why?
|
Hippocampus | 2 | 2005 | 83 |
Why?
|
Azo Compounds | 4 | 1997 | 15 |
Why?
|
Catalase | 3 | 1988 | 27 |
Why?
|
Nitriles | 4 | 1997 | 27 |
Why?
|
Cycloheximide | 2 | 1995 | 51 |
Why?
|
Phalloidine | 1 | 2006 | 3 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2002 | 35 |
Why?
|
Plasmids | 1 | 2008 | 122 |
Why?
|
Hydroxymethylglutaryl CoA Reductases | 1 | 2006 | 4 |
Why?
|
Cyclin D2 | 1 | 2006 | 2 |
Why?
|
Acetylcholine | 1 | 2006 | 49 |
Why?
|
Transplantation, Heterologous | 1 | 2006 | 57 |
Why?
|
Quality of Health Care | 1 | 2008 | 85 |
Why?
|
Peptide Nucleic Acids | 1 | 2005 | 2 |
Why?
|
Geranyltranstransferase | 1 | 2005 | 1 |
Why?
|
Acyl Coenzyme A | 1 | 2005 | 5 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 1 | 2005 | 11 |
Why?
|
Self-Evaluation Programs | 1 | 2005 | 2 |
Why?
|
Thiopental | 1 | 2005 | 7 |
Why?
|
Lovastatin | 1 | 2005 | 13 |
Why?
|
Program Evaluation | 2 | 1995 | 115 |
Why?
|
Predictive Value of Tests | 1 | 2008 | 321 |
Why?
|
Flavonoids | 1 | 2006 | 46 |
Why?
|
Social Responsibility | 1 | 2005 | 17 |
Why?
|
Palmitic Acid | 1 | 2005 | 9 |
Why?
|
Spectrophotometry | 1 | 2005 | 53 |
Why?
|
Microarray Analysis | 1 | 2005 | 24 |
Why?
|
Autonomic Nervous System | 1 | 2005 | 41 |
Why?
|
Naphthalenes | 1 | 2005 | 14 |
Why?
|
Meta-Analysis as Topic | 1 | 2005 | 30 |
Why?
|
Pyrroles | 1 | 2005 | 13 |
Why?
|
Biometry | 1 | 2005 | 32 |
Why?
|
Career Choice | 1 | 2005 | 37 |
Why?
|
Substantia Nigra | 1 | 2005 | 30 |
Why?
|
Tumor Markers, Biological | 1 | 2008 | 112 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2005 | 55 |
Why?
|
Actins | 1 | 2006 | 112 |
Why?
|
Acetylcysteine | 2 | 1988 | 42 |
Why?
|
Statistics as Topic | 1 | 2005 | 133 |
Why?
|
United States | 2 | 2003 | 604 |
Why?
|
Mice, Knockout | 2 | 2005 | 265 |
Why?
|
Fluorescent Antibody Technique | 1 | 2005 | 164 |
Why?
|
Stem Cells | 1 | 2008 | 107 |
Why?
|
Cell Adhesion | 2 | 1995 | 113 |
Why?
|
Cyclooxygenase 2 | 1 | 2006 | 77 |
Why?
|
Corpus Striatum | 1 | 2005 | 48 |
Why?
|
Caspase 9 | 1 | 2003 | 18 |
Why?
|
Pilot Projects | 1 | 2005 | 264 |
Why?
|
Cytochrome c Group | 2 | 2000 | 20 |
Why?
|
Mice, Mutant Strains | 1 | 2003 | 77 |
Why?
|
Up-Regulation | 1 | 2005 | 183 |
Why?
|
Glomerular Filtration Rate | 2 | 1983 | 33 |
Why?
|
Multiple Sclerosis | 1 | 2004 | 43 |
Why?
|
Curriculum | 1 | 2005 | 127 |
Why?
|
Cytosol | 1 | 2003 | 79 |
Why?
|
Guideline Adherence | 1 | 2003 | 64 |
Why?
|
Protein Transport | 1 | 2003 | 101 |
Why?
|
Genetic Vectors | 1 | 2005 | 139 |
Why?
|
Cytochromes c | 1 | 2003 | 29 |
Why?
|
Mutation | 2 | 2005 | 340 |
Why?
|
Indole Alkaloids | 1 | 2002 | 5 |
Why?
|
Ion Transport | 1 | 2003 | 42 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1987 | 121 |
Why?
|
Carbazoles | 1 | 2002 | 21 |
Why?
|
Hospitals, Teaching | 1 | 2003 | 57 |
Why?
|
In Situ Hybridization | 1 | 2003 | 135 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 243 |
Why?
|
Protective Agents | 1 | 2002 | 5 |
Why?
|
Mercaptoethylamines | 3 | 1980 | 2 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2002 | 22 |
Why?
|
Membrane Lipids | 2 | 1997 | 23 |
Why?
|
Models, Animal | 1 | 2003 | 85 |
Why?
|
Binding, Competitive | 1 | 2002 | 109 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 48 |
Why?
|
MAP Kinase Signaling System | 1 | 2002 | 56 |
Why?
|
Hemoptysis | 1 | 1981 | 7 |
Why?
|
History, 20th Century | 1 | 2003 | 111 |
Why?
|
Diagnosis, Differential | 1 | 2004 | 402 |
Why?
|
Endonucleases | 2 | 1975 | 13 |
Why?
|
Oligopeptides | 1 | 2002 | 56 |
Why?
|
Clinical Trials as Topic | 1 | 2005 | 251 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2001 | 31 |
Why?
|
RNA, Messenger | 2 | 2005 | 394 |
Why?
|
Cell Line | 1 | 2005 | 375 |
Why?
|
HLA-DQ Antigens | 1 | 2000 | 6 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2002 | 68 |
Why?
|
Ferrozine | 1 | 2000 | 2 |
Why?
|
Prospective Studies | 1 | 2005 | 545 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2003 | 119 |
Why?
|
Surgical Procedures, Operative | 1 | 1981 | 77 |
Why?
|
Deferoxamine | 1 | 2000 | 16 |
Why?
|
Dermatomyositis | 1 | 2000 | 16 |
Why?
|
Iron Chelating Agents | 1 | 2000 | 5 |
Why?
|
Ferric Compounds | 1 | 2000 | 20 |
Why?
|
Injections, Intraperitoneal | 1 | 2000 | 57 |
Why?
|
Mitochondria | 1 | 2003 | 100 |
Why?
|
Ascorbic Acid | 1 | 2000 | 37 |
Why?
|
Membranes | 1 | 1999 | 23 |
Why?
|
Rats, Inbred Strains | 2 | 1988 | 170 |
Why?
|
Infant | 3 | 1981 | 464 |
Why?
|
Behavior, Animal | 1 | 2000 | 77 |
Why?
|
Brain Damage, Chronic | 1 | 1998 | 23 |
Why?
|
Reference Values | 2 | 1988 | 278 |
Why?
|
Magnetic Resonance Imaging | 1 | 2004 | 294 |
Why?
|
Oncogene Proteins v-fos | 1 | 1998 | 3 |
Why?
|
Necrosis | 1 | 1998 | 82 |
Why?
|
Vinblastine | 1 | 1998 | 22 |
Why?
|
Costs and Cost Analysis | 1 | 1998 | 71 |
Why?
|
Superoxide Dismutase | 2 | 1988 | 46 |
Why?
|
Pregnancy | 1 | 2003 | 455 |
Why?
|
Glutamic Acid | 1 | 1998 | 66 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 1998 | 23 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1998 | 28 |
Why?
|
Sputum | 3 | 1980 | 26 |
Why?
|
Microtubules | 1 | 1998 | 38 |
Why?
|
Aged | 1 | 2010 | 988 |
Why?
|
Treatment Outcome | 1 | 2005 | 661 |
Why?
|
Chromatin | 1 | 1998 | 29 |
Why?
|
Blepharoptosis | 1 | 1996 | 8 |
Why?
|
Blood Coagulation Factors | 1 | 1986 | 31 |
Why?
|
Buthionine Sulfoximine | 1 | 1996 | 11 |
Why?
|
Peroxidase | 1 | 1996 | 27 |
Why?
|
Child Development | 1 | 1999 | 49 |
Why?
|
Methionine Sulfoximine | 1 | 1996 | 7 |
Why?
|
Cerebral Infarction | 1 | 1986 | 36 |
Why?
|
Single-Blind Method | 1 | 1996 | 86 |
Why?
|
AIDS Dementia Complex | 1 | 1997 | 24 |
Why?
|
Calcium | 1 | 2003 | 208 |
Why?
|
Dactinomycin | 1 | 1995 | 40 |
Why?
|
Cerebral Ventricles | 1 | 1995 | 32 |
Why?
|
Science | 1 | 1995 | 14 |
Why?
|
Molecular Weight | 2 | 1981 | 154 |
Why?
|
Sympathetic Nervous System | 1 | 1996 | 43 |
Why?
|
Wasp Venoms | 1 | 1995 | 2 |
Why?
|
Chromans | 1 | 1995 | 14 |
Why?
|
DNA, Neoplasm | 1 | 1995 | 75 |
Why?
|
Syncope | 1 | 1995 | 24 |
Why?
|
Movement Disorders | 1 | 1995 | 32 |
Why?
|
Prognosis | 1 | 1999 | 388 |
Why?
|
Medical Records | 1 | 1995 | 104 |
Why?
|
Etoposide | 1 | 1995 | 37 |
Why?
|
Mucins | 2 | 1981 | 26 |
Why?
|
Point Mutation | 2 | 2005 | 122 |
Why?
|
Biological Markers | 1 | 1996 | 262 |
Why?
|
Hydrolysis | 2 | 2003 | 57 |
Why?
|
Bacterial Proteins | 1 | 1996 | 99 |
Why?
|
Peptides | 1 | 1995 | 154 |
Why?
|
Phenol | 2 | 2000 | 3 |
Why?
|
Clinical Competence | 1 | 1995 | 130 |
Why?
|
Cytoplasm | 1 | 1993 | 108 |
Why?
|
Neurologic Examination | 1 | 1992 | 64 |
Why?
|
Glutamates | 1 | 1991 | 29 |
Why?
|
Cell Nucleus | 1 | 1995 | 169 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2003 | 176 |
Why?
|
Glutamine | 1 | 1991 | 27 |
Why?
|
Expectorants | 1 | 1980 | 3 |
Why?
|
HIV-1 | 1 | 1997 | 93 |
Why?
|
Rhode Island | 1 | 2010 | 5 |
Why?
|
Ischemic Preconditioning | 1 | 2010 | 9 |
Why?
|
Methylation | 1 | 1990 | 36 |
Why?
|
Thapsigargin | 1 | 2010 | 18 |
Why?
|
Molecular Structure | 1 | 1990 | 67 |
Why?
|
Nucleic Acid Hybridization | 1 | 2010 | 94 |
Why?
|
Tumor Burden | 1 | 2009 | 12 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 1995 | 121 |
Why?
|
Doxorubicin | 1 | 2009 | 60 |
Why?
|
Astrocytes | 1 | 1991 | 62 |
Why?
|
Dimethyl Sulfoxide | 1 | 1988 | 30 |
Why?
|
Activating Transcription Factor 4 | 1 | 2008 | 4 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2008 | 6 |
Why?
|
Glutathione Disulfide | 1 | 1988 | 10 |
Why?
|
Eating | 1 | 1988 | 37 |
Why?
|
Magnesium | 1 | 1988 | 69 |
Why?
|
Cell Hypoxia | 1 | 2008 | 31 |
Why?
|
Species Specificity | 1 | 1987 | 186 |
Why?
|
Cell Division | 1 | 1989 | 273 |
Why?
|
Databases, Genetic | 1 | 2005 | 20 |
Why?
|
Cell Proliferation | 1 | 2009 | 227 |
Why?
|
Haemophilus | 1 | 1975 | 4 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2005 | 15 |
Why?
|
DNA Restriction Enzymes | 1 | 1975 | 44 |
Why?
|
Sequence Analysis, DNA | 1 | 2005 | 110 |
Why?
|
Amino Acid Substitution | 1 | 2005 | 68 |
Why?
|
Mutation, Missense | 1 | 2005 | 59 |
Why?
|
Disinfectants | 1 | 2003 | 10 |
Why?
|
Recombinant Fusion Proteins | 1 | 2005 | 189 |
Why?
|
Nephrotic Syndrome | 1 | 1983 | 16 |
Why?
|
Temperature | 1 | 2003 | 137 |
Why?
|
Models, Chemical | 1 | 2003 | 57 |
Why?
|
Nasal Polyps | 1 | 1981 | 5 |
Why?
|
Diamines | 2 | 1980 | 1 |
Why?
|
Meconium | 1 | 1981 | 7 |
Why?
|
Pneumothorax | 1 | 1981 | 16 |
Why?
|
Mucocele | 1 | 1981 | 7 |
Why?
|
Biliary Tract Diseases | 1 | 1981 | 16 |
Why?
|
Phagocytosis | 1 | 2002 | 51 |
Why?
|
Hypertension, Portal | 1 | 1981 | 11 |
Why?
|
Intestinal Obstruction | 1 | 1981 | 24 |
Why?
|
Viscosity | 2 | 1980 | 26 |
Why?
|
HL-60 Cells | 1 | 2000 | 28 |
Why?
|
Fibroblasts | 1 | 2003 | 179 |
Why?
|
Substrate Specificity | 1 | 2000 | 90 |
Why?
|
Keratinocytes | 1 | 2000 | 36 |
Why?
|
Biological Transport | 1 | 2000 | 129 |
Why?
|
Hydrogen Peroxide | 1 | 2000 | 75 |
Why?
|
Rabbits | 2 | 1980 | 252 |
Why?
|
Macrophages | 1 | 2002 | 148 |
Why?
|
Chromatography, Thin Layer | 1 | 1997 | 25 |
Why?
|
Fatty Acids, Unsaturated | 1 | 1997 | 22 |
Why?
|
Vitamin E | 1 | 1997 | 38 |
Why?
|
Lupus Coagulation Inhibitor | 1 | 1986 | 5 |
Why?
|
Microscopy, Fluorescence | 1 | 1997 | 137 |
Why?
|
Coma | 1 | 1995 | 12 |
Why?
|
Hydrocephalus | 1 | 1995 | 20 |
Why?
|
Cysts | 1 | 1995 | 32 |
Why?
|
Recombinant Proteins | 1 | 1998 | 290 |
Why?
|
Head | 1 | 1995 | 41 |
Why?
|
Luminescent Measurements | 1 | 1995 | 35 |
Why?
|
DNA, Single-Stranded | 1 | 1995 | 32 |
Why?
|
CHO Cells | 1 | 1995 | 65 |
Why?
|
Cricetinae | 1 | 1995 | 130 |
Why?
|
Biotransformation | 1 | 1982 | 25 |
Why?
|
Carbohydrates | 1 | 1981 | 14 |
Why?
|
Dithiothreitol | 1 | 1981 | 15 |
Why?
|
Blood Proteins | 1 | 1982 | 71 |
Why?
|
Sialic Acids | 1 | 1981 | 17 |
Why?
|
Administration, Oral | 1 | 1982 | 170 |
Why?
|
Macromolecular Substances | 1 | 1981 | 92 |
Why?
|
Amino Acids | 1 | 1981 | 108 |
Why?
|
Protein Conformation | 1 | 1981 | 123 |
Why?
|
Mice, Inbred BALB C | 1 | 1980 | 176 |
Why?
|
Protein Binding | 1 | 1982 | 256 |
Why?
|
Middle Aged | 1 | 1981 | 1161 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 1975 | 9 |
Why?
|
Coliphages | 1 | 1975 | 11 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1975 | 27 |
Why?
|
Chromatography, Ion Exchange | 1 | 1975 | 36 |
Why?
|
Simian virus 40 | 1 | 1975 | 26 |
Why?
|
Adenoviridae | 1 | 1975 | 60 |
Why?
|
Saralasin | 1 | 1983 | 4 |
Why?
|
Kidney Glomerulus | 1 | 1983 | 19 |
Why?
|
DNA, Viral | 1 | 1975 | 98 |
Why?
|
Lung | 1 | 1980 | 232 |
Why?
|
Kidney Tubules, Proximal | 1 | 1983 | 9 |
Why?
|
Microscopy, Electron | 1 | 1983 | 178 |
Why?
|
Sodium | 1 | 1983 | 96 |
Why?
|
Hemodynamics | 1 | 1983 | 131 |
Why?
|
